Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on gastroenteropancreatic neuroendocrine tumors
Valentina Andreasi, Stefano Partelli, Francesca Muffatti, et al.
Digestive and Liver Disease (2020) Vol. 53, Iss. 2, pp. 171-182
Closed Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Gastroenteropancreatic Neuroendocrine Tumors
Mauro Cives, Jonathan Strosberg
CA A Cancer Journal for Clinicians (2018) Vol. 68, Iss. 6, pp. 471-487
Open Access | Times Cited: 495
Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors
Mauro Cives, Masoumeh Ghayouri, Brian Morse, et al.
Endocrine Related Cancer (2016) Vol. 23, Iss. 9, pp. 759-767
Open Access | Times Cited: 156
Sensitivity Comparison of 68Ga-OPS202 and 68Ga-DOTATOC PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase II Imaging Study
Guillaume Nicolas, N. Schreiter, Felix Kaul, et al.
Journal of Nuclear Medicine (2017) Vol. 59, Iss. 6, pp. 915-921
Open Access | Times Cited: 143
Radionuclide Therapy for Neuroendocrine Tumors
Mauro Cives, Jonathan Strosberg
Current Oncology Reports (2017) Vol. 19, Iss. 2
Closed Access | Times Cited: 134
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications
Mauro Cives, Eleonora Pellè, Davide Quaresmini, et al.
Neuroendocrinology (2019) Vol. 109, Iss. 2, pp. 83-99
Open Access | Times Cited: 101
A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in china
Jin‐Hu Fan, Yuqing Zhang, Susheng Shi, et al.
Oncotarget (2017) Vol. 8, Iss. 42, pp. 71699-71708
Open Access | Times Cited: 92
Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms
Daisuke Takayanagi, Hourin Cho, Erika Machida, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1119-1119
Open Access | Times Cited: 41
Gastroenteropancreatic neuroendocrine neoplasms: current development, challenges, and clinical perspectives
Xianbin Zhang, Yibao Fan, Rui Jing, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Safety, Biodistribution, and Radiation Dosimetry of 68Ga-OPS202 in Patients with Gastroenteropancreatic Neuroendocrine Tumors: A Prospective Phase I Imaging Study
Guillaume Nicolas, Seval Beykan, Hakim Bouterfa, et al.
Journal of Nuclear Medicine (2017) Vol. 59, Iss. 6, pp. 909-914
Open Access | Times Cited: 78
An update on the diagnosis of gastroenteropancreatic neuroendocrine neoplasms
Jiayun M. Fang, Jay Li, Jiaqi Shi
World Journal of Gastroenterology (2022) Vol. 28, Iss. 10, pp. 1009-1023
Open Access | Times Cited: 31
Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract
Mauro Cives, Jonathan Strosberg
Current Treatment Options in Oncology (2017) Vol. 18, Iss. 3
Closed Access | Times Cited: 61
Bone Metastases in Patients with Neuroendocrine Neoplasm: Frequency and Clinical, Therapeutic, and Prognostic Relevance
Michael E. Scharf, Vanessa Petry, Hanna Daniel, et al.
Neuroendocrinology (2017) Vol. 106, Iss. 1, pp. 30-37
Open Access | Times Cited: 52
A phase II study of axitinib in advanced neuroendocrine tumors
Jonathan Strosberg, Mauro Cives, Justin H. Hwang, et al.
Endocrine Related Cancer (2016) Vol. 23, Iss. 5, pp. 411-418
Open Access | Times Cited: 49
A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms
Dwight H. Owen, Brooke Benner, Lai Wei, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 4, pp. 731-741
Open Access | Times Cited: 22
Pancreatic Neuroendocrine Diagnostic Imaging Order and Reader Evaluation over Two Decades in a Tertiary Academic Center
Sara Babapour, A.M. Chen, Grace Li, et al.
Diagnostics (2025) Vol. 15, Iss. 8, pp. 960-960
Open Access
The Expanding Role of Somatostatin Analogs in Gastroenteropancreatic and Lung Neuroendocrine Tumors
Mauro Cives, Jonathan Strosberg
Drugs (2015) Vol. 75, Iss. 8, pp. 847-858
Closed Access | Times Cited: 44
Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study
Philippe Ruszniewski, Juan W. Valle, Catherine Lombard‐Bohas, et al.
Digestive and Liver Disease (2016) Vol. 48, Iss. 5, pp. 552-558
Open Access | Times Cited: 43
Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O6-methylguanine DNA methyltransferase as a biomarker for response
Dwight H. Owen, Andrew J. Alexander, Bhavana Konda, et al.
Oncotarget (2017) Vol. 8, Iss. 61, pp. 104046-104056
Open Access | Times Cited: 41
Octreotide and Lanreotide in Gastroenteropancreatic Neuroendocrine Tumors
Venkata K. Pokuri, Mei Ka Fong, Renuka Iyer
Current Oncology Reports (2016) Vol. 18, Iss. 1
Closed Access | Times Cited: 39
Imaging of Pancreatic Neuroendocrine Neoplasms
Giuditta Chiti, Giulia Grazzini, Diletta Cozzi, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 17, pp. 8895-8895
Open Access | Times Cited: 30
Long-term prognostic factors for PRRT in neuroendocrine tumors
Nils F. Trautwein, Johannes Schwenck, Johann Jacoby, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 11
A Case of a Neuroendocrine Tumor in a Liver Transplant Patient: Diagnostic and Management Difficulties
Carmen Colaci, Caterina Mercuri, Alessandro Corea, et al.
Life (2025) Vol. 15, Iss. 3, pp. 421-421
Open Access
A retrospective study of NENs and miR-224 promotes apoptosis of BON-1 cells by targeting PCSK9 inhibition
Jian’an Bai, Na He, Xiumei Hua, et al.
Oncotarget (2016) Vol. 8, Iss. 4, pp. 6929-6939
Open Access | Times Cited: 37
Neuroendocrine Tumor Therapy with Lutetium-177: A Literature Review
Muhammad Haisum Maqsood, Asim Tameez Ud Din, Ameer Khan
Cureus (2019)
Open Access | Times Cited: 33
Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms
Andrew Canakis, Linda Lee
World Journal of Gastrointestinal Endoscopy (2022) Vol. 14, Iss. 5, pp. 267-290
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top